Berchuck, Jacob E. http://orcid.org/0000-0002-7607-2428
Viscuse, Paul V.
Beltran, Himisha http://orcid.org/0000-0003-3259-2226
Aparicio, Ana http://orcid.org/0000-0003-0900-0923
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-20-1-0118, W81XWH-17-1-0653)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R37 CA241486-01A1, P50 CA211024, P50 CA140388-08A1, U01 CA224044)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Prostate Cancer Foundation
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
MD Anderson Moonshot Program The Emerson Collective
Article History
Received: 16 September 2020
Revised: 16 December 2020
Accepted: 20 January 2021
First Online: 10 February 2021
Compliance with ethical standards
:
: HB has received research funding from Janssen, AbbVie Stemcentrx, Astellas, Eli Lilly, and Millennium, and has served as advisor/consultant for Janssen, Astellas, Amgen, Astra Zeneca, Pfizer, Blue Earth Diagnostics, and Sanofi Genzyme. AA has received research funding from Janssen, Bristol Myers Squibb, Sanofi Genzyme, Glaxo Smith Kline, Daiichi Sankyo and Astra Zeneca, and has served as advisor/consultant for Janssen, Sanofi Genzyme, Glaxo Smith Kline, Astellas, Amgen and Astra Zeneca.